Compare Canopy Growth Corp (CGC) vs Ralph Lauren Corp (RL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Canopy Growth Corp vs Ralph Lauren Corp — how do they compare? Canopy Growth Corp trades at $1 (market cap $421.10M), while Ralph Lauren Corp trades at $398 (market cap $23.70B). The key difference: Ralph Lauren Corp is far larger — about 56.3× Canopy Growth Corp's market cap, and Ralph Lauren Corp pays a 0.94% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.
| CGC | RL | |
|---|---|---|
Market Cap | $421.10M | $23.70B |
Sector | Health | Consumer Cyclical |
52-Week High | $1.92 | $414.25 |
52-Week Low | $0.86 | $285.35 |
Enterprise Value | $378.55M | $24.76B |
Dividend Yield | — | 0.94% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $1.025, up 7.66% with bullish technical signals. The company shows improving fundamentals with Q1 2027 revenue growth of 13% and narrowing losses. Recent acquisitions and cost-cutting initiatives support expansion in medical and European cannabis markets. The stock trades below book value (P/B 0.86) while maintaining a P/S ratio of 1.71.
CGC presents a high-risk turnaround opportunity with improving balance sheet metrics and positive revenue momentum. However, persistent negative earnings and cash flow challenges require careful monitoring. Analyst sentiment remains divided with 33% buy ratings, reflecting the speculative nature of cannabis sector investments amid ongoing regulatory uncertainty.
Ralph Lauren (RL) trades at $396.34, down 2.59% on the day, yet maintains strong fundamentals with consistent earnings beats and robust profitability. The stock exhibits a bullish technical trend, supported by positive analyst sentiment and a consensus price target of $456.50. Recent quarters show revenue growth and margin expansion, with Q1 2027 results exceeding expectations, reinforcing the company's brand resilience and strategic execution.
The outlook for RL remains favorable, driven by earnings momentum and global demand, though risks include consumer spending volatility and competitive pressures. With 66% of analysts rating it a Buy and institutional confidence high, the stock presents a growth opportunity, but investors should monitor macroeconomic headwinds that could impact discretionary spending.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Canopy Growth Corp
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →About Ralph Lauren Corp
Founded by designer Ralph Lauren in 1967, Ralph Lauren Corp. designs, markets, and distributes lifestyle products in North America, Europe, and Asia. Its products include apparel, footwear, eyewear, jewelry, leather goods, home products, and fragrances. The company's brands include Ralph Lauren Collection, Polo Ralph Lauren, Lauren Ralph Lauren, and Double RL. Distribution channels for Ralph Lauren include wholesale (including department stores and specialty stores), retail (including company-owned retail stores and e-commerce), and licensing.
Read more on RL →
